Aphria Signs Global License Agreement with Manna Molecular Science
Aphria Corporation today announced an agreement with Manna Molecular Science, a producer of advanced transdermal patches. Based on Manna's established formulations, equipment and processes, Aphria will produce and sell patches containing cannabis oils for its established range of medical and adult brands.
"As we continue to look for other dosage forms, we are excited to offer consumers new, innovative ways to interact with cannabis," said Jakob Ripshtein, President of Aphria. "As a company at the cutting edge of cannabis innovation, Manna Molecular Science will be an important strategic partner for Aphria. Like us, they are committed to making safe, high-quality cannabis products available to a wide range of consumers around the world. "
Under the terms of the contract, Manna grants Aphria exclusive preferred seller status for a period of five years, as well as an exclusive license to produce, market, distribute, promote and sell Manna patches containing cannabis oil as an ingredient active.
"Manna is thrilled to take this monumental step with Aphria to become an internationally recognized brand. Aphria gives Manna the opportunity to distribute the Manna patch globally and share our principles of excellence in product design and manufacturing with the rest of the world, "said Nial C. DeMena, General Manager of Manna Molecular Science.
Prolonged release of transdermal active ingredients
The Manna transdermal patch has been developed by pharmaceutical scientists at the Massachusetts Institute of Technology using state-of-the-art research and product design methods. It works for all cannabinoids and is designed to work with high quality cannabis extracts, whole plants, which are printed on each patch with a pharmaceutical grade. Each patch is free of latex and allergens and administers the dose automatically through the skin for 12 hours.
Aphria is one of the world's leading cannabis companies, driven by an unwavering commitment to its people, product quality and innovation. Aphria, headquartered in Leamington, Ontario, the greenhouse capital of Canada, has set the standard for low-cost production of clean, safe, pharmaceutical-grade cannabis cannabis grown under the world's toughest conditions. natural possibilities. By focusing on untapped opportunities and leveraging the latest technology, Aphria is committed to bringing revolutionary innovations to the global cannabis market. The Company's brand portfolio is supported by extensive and expert research to meet the needs of each consumer segment. Rooted in the multigenerational expertise of our founders in commercial agriculture, Aphria creates long-term, sustainable value for its shareholders through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in more than 10 countries on 5 continents.
About Manna Molecular Science
Founded in 2015, Manna Molecular Science combines whole plant cannabis extracts with innovative technology to advance cannabis medicine in everyday life. Their lab team includes scientists with decades of experience in pharmaceutical formulation, analytical chemistry and product development.
SOURCE Aphria Inc.